Published in TB and Outbreaks Week, January 22nd, 2008
"Sixty-eight IMID patients with ( n = 35) or without ( n = 33) LTBI according to clinicoradiographic findings or TST results ( 10 mm cutoff value) underwent cell proliferation assessed by thymidine incorporation and PKH-26 dilution assays, and IFN gamma-release enzyme-linked immunosorbent spot ( ELISPOT) assays with TB-specific antigens. In...
Want to see the full article?
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of TB and Outbreaks Week